Stock Track | STAR SPORTS MED Soars 181.22% on IPO Debut Following Record 7,823 Times Oversubscription

Stock Track

05/05

STAR SPORTS MED (01609) surged 181.22% intraday on its debut trading session, reflecting overwhelming investor demand for the medical device company's initial public offering.

The explosive price movement follows an extraordinarily oversubscribed IPO, with the Hong Kong public offering receiving 7,823.13 times more applications than available shares. The international placement was also oversubscribed at 10.41 times, indicating strong institutional interest. The company raised approximately HK$758.4 million in net proceeds from the global offering.

Star Sports Medicine is China's largest domestic sports medicine implant and instrument provider, holding approximately 6.5% market share in the segment. The company's strong market position and growth prospects in China's healthcare sector contributed to the exceptional investor enthusiasm surrounding its market debut.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1121276220"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1121276220\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1121276220?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-05 09:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1121276220","market":"sg","top_or_hot":-1,"title":"Stock Track | STAR SPORTS MED Soars 181.22% on IPO Debut Following Record 7,823 Times Oversubscription","media":"Stock Track","content":"<p>STAR SPORTS MED (01609) surged 181.22% intraday on its debut trading session, reflecting overwhelming investor demand for the medical device company's initial public offering.</p><p>The explosive price movement follows an extraordinarily oversubscribed IPO, with the Hong Kong public offering receiving 7,823.13 times more applications than available shares. The international placement was also oversubscribed at 10.41 times, indicating strong institutional interest. The company raised approximately HK$758.4 million in net proceeds from the global offering.</p><p>Star Sports Medicine is China's largest domestic sports medicine implant and instrument provider, holding approximately 6.5% market share in the segment. The company's strong market position and growth prospects in China's healthcare sector contributed to the exceptional investor enthusiasm surrounding its market debut.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | STAR SPORTS MED Soars 181.22% on IPO Debut Following Record 7,823 Times Oversubscription</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | STAR SPORTS MED Soars 181.22% on IPO Debut Following Record 7,823 Times Oversubscription\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-05 09:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>STAR SPORTS MED (01609) surged 181.22% intraday on its debut trading session, reflecting overwhelming investor demand for the medical device company's initial public offering.</p><p>The explosive price movement follows an extraordinarily oversubscribed IPO, with the Hong Kong public offering receiving 7,823.13 times more applications than available shares. The international placement was also oversubscribed at 10.41 times, indicating strong institutional interest. The company raised approximately HK$758.4 million in net proceeds from the global offering.</p><p>Star Sports Medicine is China's largest domestic sports medicine implant and instrument provider, holding approximately 6.5% market share in the segment. The company's strong market position and growth prospects in China's healthcare sector contributed to the exceptional investor enthusiasm surrounding its market debut.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01609","symbol_name":"天星医疗","start_time":0,"source_url":"","article_id":"1121276220","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1121276220","pubTimestamp":1777944969,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"STAR SPORTS MED (01609) surged 181.22% intraday on its debut trading session, reflecting overwhelming investor demand for the medical device company's initial public offering.The explosive price...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01609":"天星医疗"},"translate_title":"股票赛道|Star Sports MED IPO首秀飙升181.22%超额认购创纪录7823倍","themeId":"a7761229170f08698a0131c7dfef2f92","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01609":1},"content_text":"STAR SPORTS MED (01609) surged 181.22% intraday on its debut trading session, reflecting overwhelming investor demand for the medical device company's initial public offering.The explosive price movement follows an extraordinarily oversubscribed IPO, with the Hong Kong public offering receiving 7,823.13 times more applications than available shares. The international placement was also oversubscribed at 10.41 times, indicating strong institutional interest. The company raised approximately HK$758.4 million in net proceeds from the global offering.Star Sports Medicine is China's largest domestic sports medicine implant and instrument provider, holding approximately 6.5% market share in the segment. The company's strong market position and growth prospects in China's healthcare sector contributed to the exceptional investor enthusiasm surrounding its market debut.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}